<DOC>
	<DOCNO>NCT02468141</DOCNO>
	<brief_summary>To determine efficacy safety Sipjeondaebo-tang Cancer patient suffer anorexia chemotherapy . Sipjeondaebo-tang administer 4 week , 3 time per day meal . Changes FAACT scale , Anorexia VAS , Weight , BMI , Clinical laboratory test ACTH , Cortisol , Chrelin , IL-6 , ESR , CRP measure analyze .</brief_summary>
	<brief_title>Effect Sipjeondaebo-tang Cancer Related Anorexia Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Juzentaihoto</mesh_term>
	<criteria>Men woman age 20 80 year Individuals suffer cancerassociated anorexia Patients within 1 month completion chemotherapy No plan additional chemotherapy radiotherapy Anorexia visual analogue scale ( VAS ) ≥ 40/100mm Qi deficiency scale ≥ 30 Blood deficiency scale ≥ 30 Neutrophil ≥ 1,500/㎕ , platelet ≥ 100,000/㎕ Total bilirubin low upper limit normal ( 1.2 mg/㎗ ) ALT , AST low 2fold upper limit normal Creatinine low 1.5 fold upper limit normal ( 1.09 mg/㎗ ) Written informed consent participation trial Patient impossible oral intake Patient 5 year cancer diagnosis ECOG performance status score &gt; 3 Patient dementia , delirium , depression Patient complain 7 point use Numeric Rating Scale , affect appetite calorie intake , within 2 week screen Patient disease influence appetite ( hypoadrenalism , etc ) Patient take appetizer ( megestrol acetate , corticosteroid , thalidomide ) Women possibility pregnancy Others judge appropriate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>